APPB (Applied Biosciences) EBIT: $-2.83 Mil (TTM As of Dec. 2019)


APPB Applied Biosciences Corp APPB
12 GF Score
Price $0.00
View Full Analysis

What is Applied Biosciences EBIT?

Applied Biosciences APPB 12 EBIT is $-2.83 Mil as of Dec. 2019. GuruFocus rates APPB with a GF Score™ of 12/100.

Applied Biosciences's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2019 was $-1.34 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2019 was $-2.83 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Applied Biosciences's annualized ROC % for the quarter that ended in Dec. 2019 was -97.00%. Applied Biosciences's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2019 was -1,013.84%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Applied Biosciences  (OTCPK:APPB) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Applied Biosciences's annualized ROC % for the quarter that ended in Dec. 2019 is calculated as:

ROC % (Q: Dec. 2019 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2019 ) + Invested Capital (Q: Dec. 2019 ))/ count )
=-3.88 * ( 1 - 0% )/( (3.909 + 4.091)/ 2 )
=-3.88/4
=-97.00 %

where

Invested Capital(Q: Sep. 2019 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3.484 - 0.636 - ( 0.073 - max(0, 1.323 - 0.262+0.073))
=3.909

Invested Capital(Q: Dec. 2019 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3.418 - 1.132 - ( 0.021 - max(0, 2.019 - 0.214+0.021))
=4.091

Note: The Operating Income data used here is four times the quarterly (Dec. 2019) data.

2. Joel Greenblatt's definition of Return on Capital:

Applied Biosciences's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2019 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2019 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2019  Q: Dec. 2019
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-5.348/( ( (0.373 + max(-0.643, 0)) + (0.682 + max(-1.173, 0)) )/ 2 )
=-5.348/( ( 0.373 + 0.682 )/ 2 )
=-5.348/0.5275
=-1,013.84 %

where Working Capital is:

Working Capital(Q: Sep. 2019 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.066 + 0.106 + 0.017) - (0.636 + 0 + 0.196)
=-0.643

Working Capital(Q: Dec. 2019 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.076 + 0.102 + 0.015) - (1.132 + 0 + 0.234)
=-1.173

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2019) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Applied Biosciences's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2019 )
=-2.834/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied Biosciences EBIT Related Terms

Applied Biosciences EBIT Historical Data

* Premium members only.

The historical data trend for Applied Biosciences's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied Biosciences EBIT Chart

Applied Biosciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18
EBIT
-0.00 -0.02 -0.03 -0.14 -2.39

Applied Biosciences Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.39 -0.20 -0.48 -0.82 -1.34

APPB vs CNABQ, OWCP, CXUS: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Applied Biosciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Applied Biosciences EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Applied Biosciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Applied Biosciences's EV-to-EBIT falls into.


APPB
12GF Score
Applied Biosciences Corp APPB
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Applied Biosciences EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-2.83 Mil mean?
Applied Biosciences (APPB) has a EBIT of $-2.83 Mil as of Dec. 2019. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Applied Biosciences.
Is Applied Biosciences' EBIT too high?
Applied Biosciences' current EBIT is $-2.83 Mil. Overall, Applied Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Applied Biosciences' EBIT compare to CNABQ and OWCP?
Applied Biosciences' EBIT of $-2.83 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Applied Biosciences. Applied Biosciences's current EBIT is $-2.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Applied Biosciences stock overvalued right now?
Applied Biosciences (APPB) has a current EBIT of $-2.83 Mil. The current EBIT is $-2.83 Mil. Applied Biosciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Applied Biosciences (APPB), the current EBIT is $-2.83 Mil as of Dec. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Applied Biosciences Business Description

Address 112 North Curry Street, 18th Floor, Carson, NY, USA, 89703
Applied Biosciences Corp is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. The company also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to its customers.
12GF Score

Get the complete analysis for APPB

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price